Floatz logo

N-BUTYL CYANOACRYLATE

Pancreaticoduodenectomy

Minia UniversitySmall moleculePhase 1Active
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Pancreaticoduodenectomy cohort.

Same molecule, other indications

N-BUTYL CYANOACRYLATE is also rated in:

periampullary adenocarcinomaDormant
BB
Indicative ·
64 / 100
View asset →
duodenum cancerDormant
B
Indicative ·
60 / 100
View asset →
bile duct cancerDormant
B
Indicative ·
60 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →